{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:48:11Z","timestamp":1791978491663,"version":"4.4.0"},"reference-count":106,"publisher":"Impact Journals, LLC","issue":"59","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,11,21]]},"DOI":"10.18632\/oncotarget.20135","type":"journal-article","created":{"date-parts":[[2017,8,10]],"date-time":"2017-08-10T19:02:21Z","timestamp":1502391741000},"page":"100852-100862","source":"Crossref","is-referenced-by-count":158,"title":["Recent advances on uric acid transporters"],"prefix":"10.18632","volume":"8","author":[{"given":"Liuqing","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingfeng","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shougang","family":"Zhuang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China"},{"name":"Department of Medicine, Rhode Island Hospital and Brown University School of Medicine, Providence, RI 02903, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,8,10]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/BOR.0b013e328335ef38","article-title":"A prescription for lifestyle change in patients with hyperuricemia and gout","volume":"22","author":"Choi","year":"2010","journal-title":"Current Opinion Rheumatology"},{"key":"2","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.2174\/1381612811319130011","article-title":"Chronic Hyperuricemia, Uric Acid Deposit and Cardiovascular Risk","volume":"19","author":"Ferri","year":"2013","journal-title":"Current Pharmaceutical Design"},{"key":"3","first-page":"63","article-title":"Uric acid as one of the important factors in multifactorial disorders - facts and controversies","volume":"22","author":"Feher-Turkovic","year":"2011","journal-title":"Biochemia Medical"},{"key":"4","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1172\/JCI42344","article-title":"Uric acid transport and disease","volume":"120","author":"Thorens","year":"2010","journal-title":"The Journal of clinical investigation"},{"key":"5","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/acr.20344","article-title":"Hyperuricemia and incident hypertension: a systematic review and meta- analysis","volume":"63","author":"Choi","year":"2011","journal-title":"Arthritis care and research"},{"key":"6","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1681\/ASN.2005050572","article-title":"Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells","volume":"16","author":"Johnson","year":"2005","journal-title":"Journal of the American Society of Nephrology"},{"key":"7","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1681\/ASN.2014080793","article-title":"EGF Receptor Inhibition Alleviates Hyperuricemic Nephropathy","volume":"26","author":"Zhuang","year":"2015","journal-title":"Journal of the American Society of Nephrology"},{"key":"8","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1093\/rheumatology\/keq037","article-title":"Inflammation, oxidative stress and lipids: the risk triad for atherosclerosis in gout","volume":"49","author":"Krishnan","year":"2010","journal-title":"Rheumatology"},{"key":"9","doi-asserted-by":"publisher","first-page":"33807","DOI":"10.18632\/oncotarget.16995","article-title":"Pharmacologic targeting ERK1\/2 attenuates the development and progression of hyperuricemic nephropathy in rats","volume":"8","author":"Zhuang","year":"2017","journal-title":"Oncotarget"},{"key":"10","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.biopha.2017.06.022","article-title":"Saponins extracted from Dioscorea collettii rhizomes regulate the expression of urate transporters in chronic hyperuricemia rats","volume":"93","author":"Chen","year":"2017","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"11","first-page":"203","article-title":"Establishment of uric acid associated nephropathy animal model and the underlying mechanisms","volume":"31","author":"Zhuang","year":"2015","journal-title":"Chinese Journal of Nephrology"},{"key":"12","first-page":"794","article-title":"Recent advances on hyperuricemia nephropathy","volume":"30","author":"Liu","year":"2014","journal-title":"Chinese Journal of Nephrology"},{"key":"13","first-page":"876","article-title":"Recent advances on uric acid transporters","volume":"30","author":"Liu","year":"2014","journal-title":"Chinese Journal of Nephrology"},{"key":"14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/bdd.693","article-title":"Organic anion transporters: discovery, pharmacology, regulation and roles in pathophysiology","volume":"31","author":"Sweet","year":"2010","journal-title":"Biopharmaceutics and drug disposition"},{"key":"15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1152\/physrev.00025.2013","article-title":"The organic anion transporter (OAT) family: a systems biology perspective","volume":"95","author":"Wu","year":"2015","journal-title":"Physiological Reviews"},{"key":"16","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41598-017-00706-7","article-title":"Discovery and characterization of verinurad, a potent and specific inhibitor of URAT1 for the treatment of hyperuricemia and gout","volume":"7","author":"Miner","year":"2017","journal-title":"Scientific Reports"},{"key":"17","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1371\/journal.pmed.0050197","article-title":"SLC2A9 is a high-capacity urate transporter in humans","volume":"5","author":"Wallace","year":"2008","journal-title":"PLoS medicine"},{"key":"18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-3-642-14541-4_2","article-title":"andevidence of the importance of organic anion transporters (OATs) in drug therapy","author":"Burckhardt","year":"2011","journal-title":"Handbook of experimental pharmacology"},{"key":"19","doi-asserted-by":"crossref","first-page":"e28641","DOI":"10.1371\/journal.pone.0028641","article-title":"Clinical and functional characterization of URAT1 variants","volume":"6","author":"Sayer","year":"2011","journal-title":"PloS one"},{"key":"20","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/ki.2010.206","article-title":"A \u2018complexity\u2019 of urate transporters","volume":"78","author":"Campbell","year":"2010","journal-title":"Kidney international"},{"key":"21","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/01.ASN.0000107560.80107.19","article-title":"Function and localization of urate transporter 1 in mouse kidney","volume":"15","author":"Endou","year":"2004","journal-title":"Journal of the American Society of Nephrology"},{"key":"22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1440-1797.2010.01368.x","article-title":"Interactions of urate transporter URAT1 in human kidney with uricosuric drugs","volume":"16","author":"Endou","year":"2011","journal-title":"Nephrology"},{"key":"23","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s40266-017-0461-y","article-title":"Lesinurad: A Review in Hyperuricaemia of Gout","volume":"34","author":"Deeks","year":"2017","journal-title":"Drugs Aging"},{"key":"24","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s12565-016-0369-3","article-title":"Roles of organic anion transporters (OATs) in renal proximal tubules and their localization","volume":"92","author":"Anzai","year":"2017","journal-title":"Anatomical Science International"},{"key":"25","first-page":"79","article-title":"Role of Slc2a9 and Abcg2 Gene Polymorphisms in Origin of Hyperuricemia and Gout","author":"Dudchenko","year":"2016","journal-title":"Georgian Medical News"},{"key":"26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11010-016-2671-8","article-title":"Uric acid: a modulator of prostate cells and activin sensitivity","volume":"414","author":"Bahn","year":"2016","journal-title":"Molecular and Cellular Biochemistry"},{"key":"27","doi-asserted-by":"crossref","first-page":"e84996","DOI":"10.1371\/journal.pone.0084996","article-title":"Expression of SLC2A9 isoforms in the kidney and their localization in polarized epithelial cells","volume":"9","author":"Sakurai","year":"2014","journal-title":"PloS one"},{"key":"28","doi-asserted-by":"crossref","first-page":"F612","DOI":"10.1152\/ajprenal.00139.2009","article-title":"Mouse GLUT9: evidences for a urate uniporter","volume":"297","author":"Bonny","year":"2009","journal-title":"American journal of physiology Renal physiology"},{"key":"29","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0140-6736(08)61343-4","article-title":"Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study","volume":"372","author":"Witteman","year":"2008","journal-title":"Lancet"},{"key":"30","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1093\/ndt\/gfn349","article-title":"SLC2A9--a fructose transporter identified as a novel uric acid transporter","volume":"23","author":"Johnson","year":"2008","journal-title":"Nephrology, dialysis, transplantation"},{"key":"31","article-title":"Phloretin attenuates hyperuricemia-induced endothelial dysfunction through co-inhibiting inflammation and GLUT9- mediated uric acid uptake","author":"Liu","year":"2017","journal-title":"Journal of Cellular Molecular Medicine"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Preitner, Bonny, Laverri\u00e8re, Rotman, Firsov, Da Costa, Metref, Thorens. Glut9 is a major regulator of urate homeostasis and its genetic inactivation induces hyperuricosuria and urate nephropathy. 2009; 106:15501\u201315506.","DOI":"10.1073\/pnas.0904411106"},{"key":"33","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s11655-015-2052-2","article-title":"Compound Tufuling Granules ([characters: see text]) regulate glucose transporter 9 expression in kidney to in uence serum uric acid level in hyperuricemia mice","volume":"21","author":"Zhang","year":"2015","journal-title":"Chinese Journal of Integrative Medicine"},{"key":"34","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1254\/jphs.94.297","article-title":"Human organic anion transporter 4 is a renal apical organic anion\/dicarboxylate exchanger in the proximal tubules","volume":"94","author":"Endou","year":"2004","journal-title":"Journal of pharmacological sciences"},{"key":"35","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/ckj\/sfw010","article-title":"Analysis of ABCG2 and other urate transporters in uric acid homeostasis in chronic kidney disease: potential role of remote sensing and signaling","volume":"9","author":"Nigam","year":"2016","journal-title":"Clinical Kidney Journal"},{"key":"36","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000074539","article-title":"Human organic anion transporter 3 (hOAT3) can operate as an exchanger and mediate secretory urate ux","volume":"13","author":"Wolff","year":"2003","journal-title":"Cellular physiology and biochemistry"},{"key":"37","doi-asserted-by":"crossref","first-page":"13675","DOI":"10.1074\/jbc.274.19.13675","article-title":"Molecular cloning and characterization of a new multispeci c organic anion transporter from rat brain","volume":"274","author":"Endou","year":"1999","journal-title":"The Journal of biological chemistry"},{"key":"38","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1681\/ASN.V134848","article-title":"Immunolocalization of multispeci c organic anion transporters, OAT1, OAT2, and OAT3, in rat kidney","volume":"13","author":"Endou","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"key":"39","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1124\/mol.59.5.1277","article-title":"Identi cation and characterization of human organic anion transporter 3 expressing predominantly in the kidney","volume":"59","author":"Endou","year":"2001","journal-title":"Molecular pharmacology"},{"key":"40","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1152\/physiolgenomics.00207.2007","article-title":"Multiple organic anion transporters contribute to net renal excretion of uric acid","volume":"33","author":"Nigam","year":"2008","journal-title":"Physiological genomics"},{"key":"41","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1074\/jbc.272.1.617","article-title":"Molecular cloning and functional reconstitution of a urate transporter\/channel","volume":"272","author":"Abramson","year":"1997","journal-title":"The Journal of biological chemistry"},{"key":"42","doi-asserted-by":"crossref","first-page":"F150","DOI":"10.1152\/ajprenal.00333.2001","article-title":"Functional analysis and molecular model of the human urate transporter\/channel, hUAT","volume":"283","author":"Abramson","year":"2002","journal-title":"American journal of physiology Renal physiology"},{"key":"43","doi-asserted-by":"crossref","first-page":"C1926","DOI":"10.1152\/ajpcell.2001.281.6.C1926","article-title":"Localization and topology of a urate transporter\/channel, a galectin, in epithelium-derived cells","volume":"281","author":"Abramson","year":"2001","journal-title":"American journal of physiology Cell physiology"},{"key":"44","doi-asserted-by":"crossref","first-page":"F336","DOI":"10.1152\/ajprenal.00053.2010","article-title":"Uric acid increases bronectin synthesis through upregulation of lysyl oxidase expression in rat renal tubular epithelial cells","volume":"299","author":"Junwei","year":"2010","journal-title":"American journal of physiology Renal physiology"},{"key":"45","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-physiol-021113-170343","article-title":"The molecular physiology of uric acid homeostasis","volume":"77","author":"Mount","year":"2015","journal-title":"Annual review of physiology"},{"key":"46","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/bjp.2008.343","article-title":"Effect of hypouricaemic and hyperuricaemic drugs on the renal urate ef ux transporter, multidrug resistance protein 4","volume":"155","author":"Russel","year":"2008","journal-title":"British journal of pharmacology"},{"key":"47","doi-asserted-by":"crossref","first-page":"F327","DOI":"10.1152\/ajprenal.00133.2004","article-title":"Human organic anion transporter MRP4 (ABCC4) is an ef ux pump for the purine end metabolite urate with multiple allosteric substrate binding sites","volume":"288","author":"Russel","year":"2005","journal-title":"American journal of physiology Renal physiology"},{"key":"48","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bbrc.2008.12.014","article-title":"Involvement of NHERF1 in apical membrane localization of MRP4 in polarized kidney cells","volume":"379","author":"Cole","year":"2009","journal-title":"Biochemical and biophysical research communications"},{"key":"49","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0022-2275(20)31588-1","article-title":"The human ATP- binding cassette (ABC) transporter superfamily","volume":"42","author":"Chimini","year":"2001","journal-title":"Journal of Lipid Research"},{"key":"50","doi-asserted-by":"crossref","first-page":"10338","DOI":"10.1073\/pnas.0901249106","article-title":"Identi cation of a urate transporter, ABCG2, with a common functional polymorphism causing gout","volume":"106","author":"Kottgen","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"51","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/sj.ki.5002645","article-title":"Thebreast cancer resistance protein transporter ABCG2 is expressed in the human kidney proximal tubule apical membrane","volume":"73","author":"Masereeuw","year":"2008","journal-title":"Kidney international"},{"key":"52","doi-asserted-by":"crossref","first-page":"490","DOI":"10.2133\/dmpk.DMPK-14-SC-041","article-title":"Ethnic differences in ATP-binding cassette transporter, sub-family G, member 2 (ABCG2\/BCRP): genotype combinations and estimated functions","volume":"29","author":"Shinomiya","year":"2014","journal-title":"Drug metabolism and pharmacokinetics"},{"key":"53","article-title":"Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population","volume":"1","author":"Nakayama","year":"2009","journal-title":"Science Translational Medicine"},{"key":"54","doi-asserted-by":"crossref","unstructured":"Woodward, Tukaye, Cui, Greenwell, Constantoulakis, Parker, Rao, K\u00f6ttgen, Maloney, Guggino. Gout-causing Q141K mutation in ABCG2 leads to instability of the nucleotide- binding domain and can be corrected with small molecules. 2013; 110:5223\u20135228.","DOI":"10.1073\/pnas.1214530110"},{"key":"55","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/01.HYP.0000069700.62727.C5","article-title":"Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?","volume":"41","author":"Mazzali","year":"2003","journal-title":"Hypertension"},{"key":"56","doi-asserted-by":"crossref","first-page":"F1134","DOI":"10.1152\/ajprenal.00104.2008","article-title":"Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia","volume":"295","author":"Johnson","year":"2008","journal-title":"American journal of physiology Renal physiology"},{"key":"57","doi-asserted-by":"crossref","first-page":"F1238","DOI":"10.1152\/ajprenal.00164.2006","article-title":"Effects of acute and chronic L-arginine treatment in experimental hyperuricemia","volume":"292","author":"Franco","year":"2007","journal-title":"American journal of physiology Renal physiology"},{"key":"58","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1523-1755.2005.00074.x","article-title":"Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats","volume":"67","author":"Herrera-Acosta","year":"2005","journal-title":"Kidney international"},{"key":"59","doi-asserted-by":"crossref","first-page":"F471","DOI":"10.1152\/ajprenal.00560.2012","article-title":"Uric acid-induced phenotypic transition of renal tubular cells as a novel mechanism of chronic kidney disease","volume":"304","author":"Kang","year":"2013","journal-title":"American journal of physiology Renal physiology"},{"key":"60","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1097\/01.ASN.0000034910.58454.FD","article-title":"A role for uric acid in the progression of renal disease","volume":"13","author":"Johnson","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"key":"61","first-page":"F373","article-title":"Uric acid inhibits renal proximal tubule cell proliferation via at least two signaling pathways involving PKC, MAPK, cPLA2, NF-kappaB","author":"Taub","year":"2007","journal-title":"American journal of physiology Renal physiology"},{"key":"62","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1182\/blood.V89.2.577","article-title":"The role of hyperuricemia in the increased cytokine production after lipopolysaccharide challenge in neutropenic mice","volume":"89","author":"van der Meer","year":"1997","journal-title":"Blood"},{"key":"63","doi-asserted-by":"crossref","first-page":"F116","DOI":"10.1152\/ajprenal.00160.2006","article-title":"Effect of elevated serum uric acid on cisplatin-induced acute renal failure","volume":"292","author":"Ejaz","year":"2007","journal-title":"American journal of physiology Renal physiology"},{"key":"64","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1093\/ndt\/gft029","article-title":"Uric acid and chronic kidney disease: which is chasing which?","volume":"28","author":"Ritz","year":"2013","journal-title":"Nephrology, dialysis, transplantation"},{"key":"65","doi-asserted-by":"crossref","first-page":"e0176058","DOI":"10.1371\/journal.pone.0176058","article-title":"Metabolic syndrome, serum uric acid and renal risk in patients with T2D","volume":"12","author":"Pontremoli","year":"2017","journal-title":"PloS one"},{"key":"66","doi-asserted-by":"crossref","first-page":"e0170393","DOI":"10.1371\/journal.pone.0170393","article-title":"Serum Uric Acid, Progression of Kidney Disease: A Longitudinal Analysis and Mini-Review","volume":"12","author":"Huang","year":"2017","journal-title":"PloS one"},{"key":"67","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/j.ajkd.2012.07.021","article-title":"Uric acid as a target of therapy in CKD","volume":"61","author":"Targher","year":"2013","journal-title":"American journal of kidney diseases"},{"key":"68","doi-asserted-by":"crossref","first-page":"F875","DOI":"10.1152\/ajprenal.0352.2000","article-title":"Expression of the urate transporter\/channel is developmentally regulated in human kidneys","volume":"281","author":"Abramson","year":"2001","journal-title":"American journal of physiology Renal physiology"},{"key":"69","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1021\/jm1015022","article-title":"Developing potent human uric acid transporter 1 (hURAT1) inhibitors","volume":"54","author":"Endou","year":"2011","journal-title":"Journal of Medicinal Chemistry"},{"key":"70","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0026-0495(68)90132-7","article-title":"Hyperlipidemia in primary gout","volume":"17","author":"Barlow","year":"1968","journal-title":"Metabolism: clinical and experimental"},{"key":"71","doi-asserted-by":"crossref","first-page":"E76","DOI":"10.1002\/clc.20511","article-title":"Epidemiological association between uric acid concentration in plasma, lipoprotein(a), and the traditional lipid pro le","volume":"33","author":"Cesare Guidi","year":"2010","journal-title":"Clinical cardiology"},{"key":"72","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3126\/ajms.v4i2.7893","article-title":"A correlative study of uric acid with lipid profile","volume":"4","author":"Sharma","year":"2013","journal-title":"Asian Journal of Medical Science"},{"key":"73","first-page":"71","article-title":"Is there a link between hyperuricemia, morning blood pressure surge, and non-dipping blood pressure pattern in metabolic syndrome patients?","volume":"6","author":"Ozdemir","year":"2013","journal-title":"International journal of nephrology and renovascular disease"},{"key":"74","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/15257770.2013.854382","article-title":"Feno brate increases serum creatinine in a patient with familial nephropathy associated to hyperuricemia","volume":"33","author":"Puig","year":"2014","journal-title":"Nucleosides, nucleotides and nucleic acids"},{"key":"75","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/ard.54.2.90","article-title":"Increased concentrations of serum Lp(a) lipoprotein in patients with primary gout","volume":"54","author":"Higashino","year":"1995","journal-title":"Annals of the Rheumatic Diseases"},{"key":"76","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2741\/3950","article-title":"Uric acid, hyperuricemia and vascular diseases","volume":"17","author":"Yang","year":"2012","journal-title":"Frontiers in bioscience"},{"key":"77","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1177\/0300060516673923","article-title":"Relationship between hyperuricemia and risk of coronary heart disease in a middle-aged and elderly Chinese population","volume":"45","author":"Lei","year":"2017","journal-title":"Journal of International Medical Research"},{"key":"78","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s10067-015-2919-9","article-title":"Serum uric acid: an independent predictive marker for coronary artery disease","volume":"34","author":"Sertoglu","year":"2015","journal-title":"Clinical Rheumatology"},{"key":"79","doi-asserted-by":"crossref","first-page":"E1462","DOI":"10.21037\/jtd.2016.11.39","article-title":"Serum uric acid levels and cardiovascular disease: the Gordian knot","volume":"8","author":"Rodriguez-Gonzalez","year":"2016","journal-title":"Journal of Thoracic Disease"},{"key":"80","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12872-015-0059-4","article-title":"The association between serum uric acid levels, metabolic syndrome and cardiovascular disease in middle aged and elderly Chinese: results from the DYSlipidemia International Study","volume":"15","author":"Mu","year":"2015","journal-title":"BMC cardiovascular disorders"},{"key":"81","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00592-014-0611-1","article-title":"Serum uric acid predicts vascular complications in adults with type 1 diabetes: the coronary artery calcification in type 1 diabetes study","volume":"51","author":"Snell-Bergeon","year":"2014","journal-title":"Acta diabetologica"},{"key":"82","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/acr.20065","article-title":"Hyperuricemia and coronary heart disease: a systematic review and meta-analysis","volume":"62","author":"Albert","year":"2010","journal-title":"Arthritis care & research"},{"key":"83","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1185\/03007995.2015.1087980","article-title":"Inflammation: a possible mechanism for a causative role of hyperuricemia\/gout in cardiovascular disease","volume":"31","author":"Becker","year":"2015","journal-title":"Current medical research and opinion"},{"key":"84","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nrrheum.2014.124","article-title":"Improving cardiovascular and renal outcomes in gout: what should we target?","volume":"10","author":"Bardin","year":"2014","journal-title":"Nature Reviews Rheumatology"},{"key":"85","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.amjmed.2011.04.036","article-title":"Renal calculosis of Pandolfo III Malatesta (1370-1427)","volume":"124","author":"Fornaciari","year":"2011","journal-title":"The American journal of medicine"},{"key":"86","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.2337\/db09-0014","article-title":"Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort study","volume":"58","author":"Parving","year":"2009","journal-title":"Diabetes"},{"key":"87","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2337\/dc10-0227","article-title":"High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up","volume":"33","author":"Krolewski","year":"2010","journal-title":"Diabetes care"},{"key":"88","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1093\/ndt\/gfp740","article-title":"Serum uric acid levels predict the development of albuminuria over 6 years in patients with type 1 diabetes: findings from the Coronary Artery Calcification in Type 1 Diabetes study","volume":"25","author":"Snell-Bergeon","year":"2010","journal-title":"Nephrology, dialysis, transplantation"},{"key":"89","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s11892-013-0381-0","article-title":"Uric acid lowering to prevent kidney function loss in diabetes: the preventing early renal function loss (PERL) allopurinol study","volume":"13","author":"Consortium","year":"2013","journal-title":"Current diabetes reports"},{"key":"90","doi-asserted-by":"crossref","first-page":"e6901","DOI":"10.1097\/MD.0000000000006901","article-title":"Combined effect of serum gamma-glutamyltransferase and uric acid on incidence of diabetes mellitus: A longitudinal study","volume":"96","author":"Kim","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"91","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1111\/j.1523-1755.2005.00273.x","article-title":"Hyperuricemia induces endothelial dysfunction","volume":"67","author":"Johnson","year":"2005","journal-title":"Kidney international"},{"key":"92","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/hy1101.092839","article-title":"Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism","volume":"38","author":"Johnson","year":"2001","journal-title":"Hypertension"},{"key":"93","first-page":"360","article-title":"Clustering of cardiovascular risk factors mimicking the human metabolic syndrome X in eNOS null mice","volume":"133","author":"Scherrer","year":"2003","journal-title":"Swiss medical weekly"},{"key":"94","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1385\/CBB:32:1-3:123","article-title":"Evolution of urate- degrading enzymes in animal peroxisomes","volume":"32","author":"Noguchi","year":"2000","journal-title":"Cell Biochemistry Biophysics"},{"key":"95","first-page":"535686","article-title":"Renal oxidative stress induced by long-term hyperuricemia alters mitochondrial function and maintains systemic hypertension","volume":"2015","author":"Lozada","year":"2015","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"96","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.metabol.2015.10.026","article-title":"Hyperuricemia induces hypertension through activation of renal epithelial sodium channel (ENaC)","volume":"65","author":"Liang","year":"2016","journal-title":"Metabolism: clinical and experimental"},{"key":"97","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1186\/s12906-015-0950-7","article-title":"Antioxidative phytochemicals from Rhododendron oldhamii Maxim. leaf extracts reduce serum uric acid levels in potassium oxonate-induced hyperuricemic mice","volume":"15","author":"Wu","year":"2015","journal-title":"BMC Complement and Alternative Medicine"},{"key":"98","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/07315724.1992.10718238","article-title":"Changes in serum and urinary uric acid levels in normal human subjects fed purine-rich foods containing different amounts of adenine and hypoxanthine","volume":"11","author":"Savoie","year":"1992","journal-title":"Journal of the American College Nutrition"},{"key":"99","first-page":"27","article-title":"Establishment of hyperuricemia rat model with renal damage","volume":"33","author":"Gao","year":"2012","journal-title":"Journal of Tongji University (Medical Science)"},{"key":"100","first-page":"18","article-title":"Xijian cao\u2019s renal protective role through decreasing serum uric acid","volume":"35","author":"Yu","year":"2007","journal-title":"Journal of Acta Chinese Medicine, Pharmacology"},{"key":"101","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1159\/000438517","article-title":"Chinese Herbal Formulas Si-Wu-Tang and Er-Miao-San Synergistically Ameliorated Hyperuricemia and Renal Impairment in Rats Induced by Adenine and Potassium Oxonate","volume":"37","author":"Wang","year":"2015","journal-title":"Cellular physiology and biochemistry"},{"key":"102","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.lfs.2012.08.013","article-title":"Anti- in ammatory and immunomodulatory effects of iridoid glycosides from Paederia scandens (LOUR.) MERRILL (Rubiaceae) on uric acid nephropathy rats","volume":"91","author":"Zhou","year":"2012","journal-title":"Life Sciences"},{"key":"103","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1681\/ASN.V1251001","article-title":"Diabetes insipidus in uricase-deficient mice: a model for evaluating therapy with poly (ethylene glycol)-modified uricase","volume":"12","author":"Hershfield","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"key":"104","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1056\/NEJM199602153340707","article-title":"The management of gout","volume":"334","author":"Emmerson","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"105","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1073\/pnas.91.2.742","article-title":"Hyperuricemia and urate nephropathy in urate oxidase-deficient mice","volume":"91","author":"Caskey","year":"1994","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"106","first-page":"222","article-title":"Crystal ball gazing: new therapeutic targets for hyperuricaemia and gout","volume":"48","author":"Merriman","year":"2009","journal-title":"Rheumatology"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.20135","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T04:32:16Z","timestamp":1719376336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.20135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,10]]},"references-count":106,"journal-issue":{"issue":"59","published-print":{"date-parts":[[2017,11,21]]}},"alternative-id":["20135","29246027"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.20135","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,10]]}}}